rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Optex Systems Holdings, Inc.

OPXS · Nasdaq

Health CareLife-science toolsNot moving yet

OPXS stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 32 weeks. It is 15.5% below that average now. Life Science Tools & Research Services: 58% of its 79 stocks in an uptrend (+6 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 32
Industry in uptrend
58% +6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.2M
Officials’ trades on record
0
Institutions holding
38 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

22 Apr – 21 Oct
26%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months6
Buyers · sellers0 · 2
WhoDidSharesTraded
Chad Michael GeorgeCEO and Presidentsold7,035at $13.6211 Mar 2026filed 13 Mar 2026
Danny Robert SchoeningDirector, 10% ownersold2,815at $13.558 Jan 2026filed 9 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold26,109at $14.118 Jan 2026filed 9 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold27,946at $13.447 Jan 2026filed 9 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold14,066at $13.026 Jan 2026filed 6 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold5,495at $13.085 Jan 2026filed 6 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold4,451at $13.092 Jan 2026filed 6 Jan 2026
Danny Robert SchoeningDirector, 10% ownersold29,696at $13.992 Jan 2026filed 6 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders38+3 on the quarter
New · exited7 · 4
Reported value$39.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
WASATCH ADVISORS LPadded · filed 10 Jul 2026634,671$8.9M+236,523+59.4%
Topline Capital Management, LLCreduced · filed 14 Aug 2026449,363$6.3M-130,000−22.4%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.added · filed 14 Aug 2026339,740$4.8M+16,265+5.0%
LPL Financial LLCreduced · filed 7 Aug 2026225,007$3.2M-30,865−12.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026218,622$3.1M+19,817+10.0%
Archon Capital Management LLCadded · filed 14 Aug 2026196,124$2.8M+538+0.3%
Meros Investment Management, LPnew · filed 14 Aug 202695,312$1.3M+95,312
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202666,501$934K+3,776+6.0%
Mink Brook Asset Management LLCreduced · filed 14 Aug 202662,284$874K-2,555−3.9%
MARSHALL WACE, LLPreduced · filed 13 Aug 202651,518$723K-47,458−47.9%
31 Mar 2023 – 30 Jun 2026
32037Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Chad Michael George Company insiderCEO and President · last 11 Mar 20260 · 1
Danny Robert Schoening Company insiderDirector, 10% owner · last 8 Jan 20263 · 10
Karen Lea Hawkins Company insiderCFO · last 18 Dec 20254 · 2
Dale E. Lehmann Company insiderDirector · last 4 Nov 20256 · 3
Judd Dayton Company insiderDirector, 10% owner · last 4 Nov 20250 · 3
R. Rimmy Malhotra Company insiderDirector · last 4 Nov 20254 · 2
Topline Capital Management, LLC Company insiderOther · last 30 Jun 20252 · 5
Topline Capital Partners, LP Company insider10% owner · last 30 Jun 20252 · 5
Lawrence F. Hagenbuch Company insiderDirector · last 1 Sep 20211 · 0
Ephraim G. Fields Company insider10% owner · last 26 Aug 20212 · 3
Longview Fund Lp Company insider10% owner · last 17 Jul 20180 · 38
Merrick D. Okamoto Company insiderDirector · last 19 Dec 20130 · 0

Same industry

OABI OmniAbLeading+72%
TXG 10x GenomicsLeading+69%
ILMN IlluminaLeading+53%
AVTR AvantorLeading+52%
RVTY RevvityLeading+39%
ABSI AbsciLeading+36%
MASS 908 DevicesLeading+35%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 28 Sep 202529.2%
Operating profit marginFY 2025 · to 28 Sep 202517.3%
Free cash flow marginFY 2025 · to 28 Sep 202515.6%
Return on capital employedFY 2025 · to 28 Sep 202528.0%
Cash conversionFY 2025 · to 28 Sep 2025135%
Share count trendFY 2025 · to 16 Dec 20250.2%
Cash and equivalentsFY 2025 · to 28 Sep 2025$6.4M
Free cash flowFY 2025 · to 28 Sep 2025$6.4M

Analyst forecasts

No analyst forecasts yet.